TriCares said today that it raised nearly $26 million in a Series B round for the tricuspid valve replacement technology it’s developing. Paris- and Munich-based TriCares said the €22 million ($25.8 million) round was led by new backers Wellington Partners, Andera Partners and BioMed Partners, plus existing investors CM-CIC Innovation, CapDecisif Management and GO Capital. Proceeds from the […]